Trial Outcomes & Findings for Lifting and Tightening of the Face and Neck Following an Increased Density Treatment (NCT NCT01519206)

NCT ID: NCT01519206

Last Updated: 2017-12-11

Results Overview

Improvement in overall lifting and tightening of skin was completed by three masked assessors, completing a qualitative assessment of pre- and post-treatment photographs. Masked photo pairs of pre/post treatment photos of each treated subject were provided to each assessor. Each photo pair was consistent in lighting, position, focus. The visit interval of each photo was NOT marked. Each assessor's review was completed independently, with no input from others, assessing the photos for improvement. If improvement was seen, the blinded assessor was to choose the post-treatment photo. Categories of assessment included Improved, No Change, or Incorrect post-treatment photo chosen. The majority assessment among the 3 blinded assessors for each subject was reported.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

32 participants

Primary outcome timeframe

Baseline to 90 days post treatment

Results posted on

2017-12-11

Participant Flow

Thirty-five (35) subjects were enrolled, 3 were deemed screen failures. Thirty-two (32) received study treatment. The first subject was treated on August 3, 2011 and the last subject was treated on 11/28/2011. The last patient follow-up for the trial was 11/21/2012.

Participant milestones

Participant milestones
Measure
Ultherapy Treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Overall Study
STARTED
32
Overall Study
COMPLETED
27
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Ultherapy Treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Overall Study
Lost to Follow-up
3
Overall Study
Missed Visit
2

Baseline Characteristics

Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ultherapy Treatment
n=32 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Age, Continuous
55 years
n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Caucasian
30 participants
n=5 Participants
Race/Ethnicity, Customized
African American/Black
1 participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic/Latino
1 participants
n=5 Participants
Region of Enrollment
United States
32 participants
n=5 Participants
Fitzpatrick Skin Type
I
1 participants
n=5 Participants
Fitzpatrick Skin Type
II
24 participants
n=5 Participants
Fitzpatrick Skin Type
III
6 participants
n=5 Participants
Fitzpatrick Skin Type
IV
0 participants
n=5 Participants
Fitzpatrick Skin Type
V
1 participants
n=5 Participants
Fitzpatrick Skin Type
VI
0 participants
n=5 Participants
Body Mass Index (BMI)
23.3 kg/m˄2
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 90 days post treatment

Population: Thirty-five (35) subjects were enrolled; 3 were screen failures. Thirty-two (32) subjects received study treatment. Three (3) subjects were lost-to-follow-up.

Improvement in overall lifting and tightening of skin was completed by three masked assessors, completing a qualitative assessment of pre- and post-treatment photographs. Masked photo pairs of pre/post treatment photos of each treated subject were provided to each assessor. Each photo pair was consistent in lighting, position, focus. The visit interval of each photo was NOT marked. Each assessor's review was completed independently, with no input from others, assessing the photos for improvement. If improvement was seen, the blinded assessor was to choose the post-treatment photo. Categories of assessment included Improved, No Change, or Incorrect post-treatment photo chosen. The majority assessment among the 3 blinded assessors for each subject was reported.

Outcome measures

Outcome measures
Measure
Ultherapy Treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 90 Days Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 180 Days Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 1 Year Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Improvement in Overall Lifting and Tightening of Skin
48 percentage of participants improved

SECONDARY outcome

Timeframe: Baseline to 60 days, 90 days, 180 days and 1 year post-treatment

Population: Three (3) subjects were lost-to-follow-up. Two (2) additional subjects missed the 1 year visit.

Improvement was assessed based on Global Aesthetic Improvement Scale (GAIS) scores. The GAIS was completed based on a live assessment of the subject and a photographic assessment comparing post-treatment photos to baseline photos. The PGAIS was completed by a clinician assessor; SGAIS was completed by the study subject. The GAIS is a 5-point scale (1-5) describing an overall assessment as follows: 1. \- Very Much Improved 2. \- Much Improved 3. \- Improved 4. \- No Change 5. \- Worse

Outcome measures

Outcome measures
Measure
Ultherapy Treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 90 Days Post-treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 180 Days Post-treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 1 Year Post-treatment
n=27 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
PGAIS - Very Much Improved
7 Percentage of Participants
14 Percentage of Participants
7 Percentage of Participants
7 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
PGAIS - Much Improved
28 Percentage of Participants
24 Percentage of Participants
10 Percentage of Participants
22 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
PGAIS - Improved
59 Percentage of Participants
41 Percentage of Participants
48 Percentage of Participants
70 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
PGAIS - No Change
7 Percentage of Participants
21 Percentage of Participants
31 Percentage of Participants
0 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
PGAIS - Worse
0 Percentage of Participants
0 Percentage of Participants
3 Percentage of Participants
0 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
SGAIS - Very Much Improved
3 Percentage of Participants
3 Percentage of Participants
0 Percentage of Participants
4 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
SGAIS - Much Improved
10 Percentage of Participants
17 Percentage of Participants
17 Percentage of Participants
7 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
SGAIS - Improved
48 Percentage of Participants
41 Percentage of Participants
52 Percentage of Participants
41 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
SGAIS - No Change
34 Percentage of Participants
34 Percentage of Participants
24 Percentage of Participants
41 Percentage of Participants
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
SGAIS - Worse
3 Percentage of Participants
3 Percentage of Participants
7 Percentage of Participants
7 Percentage of Participants

SECONDARY outcome

Timeframe: During Ulthera treatment

Subjects' sensory response to the Ulthera treatment exposures were recorded for each anatomical region treated using a validated Numeric Rating Scale (0-10), with 1 representing no pain and 10 representing the worst pain possible. Subjects rated pain for each transducer, in each treatment region. For statistical analyses, NRS scores were averaged for each transducer depth.

Outcome measures

Outcome measures
Measure
Ultherapy Treatment
n=32 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 90 Days Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 180 Days Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 1 Year Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Subjects' Assessment of Pain
4.5mm Transducer
4.6 Units on a scale
Interval 0.0 to 9.0
Subjects' Assessment of Pain
3.0mm Transducer
3.6 Units on a scale
Interval 0.0 to 7.0

SECONDARY outcome

Timeframe: Baseline to 90 days, 180 days and 1 year post-treatment

Population: Three (3) subjects were lost-to-follow-up. Two (2) subjects missed the 1 year visit.

Subject satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 90 days, 180 days and 1 year post-treatment. Subjects indicated how satisfied they were with their study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and post-treatment photographs were available for viewing at each follow-up visit interval. Subjects also had a mirror available for real time assessment, comparing their image in the mirror with pre-treatment and post-treatment photos.

Outcome measures

Outcome measures
Measure
Ultherapy Treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 90 Days Post-treatment
n=29 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 180 Days Post-treatment
n=27 Participants
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Treated Subjects GAIS Data - 1 Year Post-treatment
Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth.
Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment
Very Satisfied
21 Percentage of Participants
10 Percentage of Participants
7 Percentage of Participants
Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment
Satisfied
48 Percentage of Participants
59 Percentage of Participants
41 Percentage of Participants
Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment
Dissatisfied
24 Percentage of Participants
21 Percentage of Participants
37 Percentage of Participants
Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment
Very Dissatisfied
7 Percentage of Participants
10 Percentage of Participants
15 Percentage of Participants

Adverse Events

Ultherapy Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Public Disclosure Manager

Merz Pharmaceuticals

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place